Evaluation of Ascorbate-Meglumine Therapeutic for SRS
Clinical trial NCT06433791 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06433791
- Sponsor
- LadeRx LLC
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-09
- Primary completion
- 2025-05-17
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.